ALCOA+
Data integrity principles: Attributable, Legible, Contemporaneous, Original, Accurate (plus Complete, Consistent, Enduring, Available).
Definition
ALCOA+ is the data integrity framework regulators apply to clinical, manufacturing, and quality records. The '+' adds Complete, Consistent, Enduring, and Available to the original ALCOA principles. ALCOA stands for Attributable, Legible, Contemporaneous, Original and Accurate. Regulators including FDA, the MHRA and the WHO use these principles in data integrity guidance, and they apply to paper and electronic records alike. For electronic systems, the principles connect to 21 CFR Part 11 controls such as audit trails, access controls and validated systems.What this means in practice
Common in 21 CFR Part 11, EU Annex 11, and ISO 14155 audits. EHR exports, eCRF audit trails, and manual transcription practices are common ALCOA+ findings.Examples
- A clinical trial site implements an electronic data capture system with audit trails that record every modification, demonstrating the "Attributable," "Contemporaneous," and "Enduring" aspects of ALCOA+.
- A medical device manufacturer meticulously documents all calibration records for manufacturing equipment, ensuring the data is "Legible," "Original," and "Accurate" for regulatory audits.
- During a software update for a diagnostic device, all historical patient data remains accessible and verifiable, fulfilling the "Available" and "Consistent" principles of ALCOA+.
- •Failing to implement robust access controls can compromise the "Attributable" principle of ALCOA+.
- •Inadequate validation of electronic systems can lead to data integrity issues, particularly concerning the "Accurate" and "Consistent" principles.
- •Not maintaining comprehensive audit trails makes it difficult to prove data integrity over time, violating the "Complete" and "Enduring" principles.
- •Assuming that commercial off-the-shelf software inherently meets ALCOA+ without proper configuration and validation is a common mistake.
Frequently asked questions
Cross-references
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsMore in Clinical & Trials
· Same categoryTrial design that pre-specifies opportunities to modify aspects (sample size, arms, endpoints) based on interim data.
Any untoward medical occurrence in a subject, whether or not related to the device.
An IVD's ability to detect small quantities of an analyte.
Trial design that uses Bayesian statistics, often incorporating prior data from related studies or registries.
Where this term appears across MedTech Terms.
Latest in MedTech
Sources
3 sourcesSources support the definition or relevant regulatory context, not necessarily every claim on this page. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.
- 1FDA Data Integrity GuidanceTier 2 VerifiedFDAfda.gov
- 2ICH GuidelinesTier 2 VerifiedICHich.org
- 3ISO 14155 Standard PageTier 1 VerifiedISOiso.org
Inline markers like [1] jump to the matching reference above.